Stay updated on Risankizumab in Psoriatic Arthritis Clinical Trial
Sign up to get notified when there's something new on the Risankizumab in Psoriatic Arthritis Clinical Trial page.

Latest updates to the Risankizumab in Psoriatic Arthritis Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedNew reader guidance sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention label formatting changed from 'Intervention / Treatment' to 'Intervention/Treatment'. A recruitment-status note ('No longer looking for participants') was added and the page revision indicator updated to 'Revision: v3.6.0'.SummaryDifference0.2%

- Check21 days agoChange DetectedA new revision label with v3.5.5 has been added to the page, signaling an updated document version without changing the substantive content.SummaryDifference0.0%

- Check35 days agoChange DetectedThe Related Info section, the AbbVie sponsor block, and the Helpful Links Provided by footer were removed. This reduces sponsor attribution and auxiliary links from the page while preserving the main study details.SummaryDifference0.1%

- Check43 days agoChange DetectedThe page revision was updated from v3.5.3 to v3.5.4, signaling a newer version of the page's documentation for the study record (likely updates to linked documents or notices, not changes to study results).SummaryDifference0.0%

- Check57 days agoChange DetectedThe Study Documents section shows Revision: v3.5.3, replacing Revision: v3.5.2. This indicates an updated version of the documents provided by AbbVie.SummaryDifference0.0%

- Check71 days agoChange DetectedRevision: v3.5.2 was added and Revision: v3.5.0 was removed.SummaryDifference0.0%

Stay in the know with updates to Risankizumab in Psoriatic Arthritis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Risankizumab in Psoriatic Arthritis Clinical Trial page.